203 related articles for article (PubMed ID: 21923952)
1. In Silico discovery of transcription factors as potential diagnostic biomarkers of ovarian cancer.
Kaur M; MacPherson CR; Schmeier S; Narasimhan K; Choolani M; Bajic VB
BMC Syst Biol; 2011 Sep; 5():144. PubMed ID: 21923952
[TBL] [Abstract][Full Text] [Related]
2. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
3. Understanding the transcriptional regulation of cervix cancer using microarray gene expression data and promoter sequence analysis of a curated gene set.
Srivastava P; Mangal M; Agarwal SM
Gene; 2014 Feb; 535(2):233-8. PubMed ID: 24291025
[TBL] [Abstract][Full Text] [Related]
4. Advanced stage, high-grade primary tumor ovarian cancer: a multi-omics dissection and biomarker prediction process.
Honar YS; Javaher S; Soleimani M; Zarebkohan A; Farhadihosseinabadi B; Tohidfar M; Abdollahpour-Alitappeh M
Sci Rep; 2023 Oct; 13(1):17265. PubMed ID: 37828118
[TBL] [Abstract][Full Text] [Related]
5. Single-cell and transcriptomic analyses reveal the influence of diabetes on ovarian cancer.
Zhao Z; Wang Q; Zhao F; Ma J; Sui X; Choe HC; Chen P; Gao X; Zhang L
BMC Genomics; 2024 Jan; 25(1):1. PubMed ID: 38166541
[TBL] [Abstract][Full Text] [Related]
6. Profiling and bioinformatics analyses reveal differential circular RNA expression in ovarian cancer.
Wang J; Wu A; Yang B; Zhu X; Teng Y; Ai Z
Gene; 2020 Jan; 724():144150. PubMed ID: 31589961
[TBL] [Abstract][Full Text] [Related]
7. Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data.
Gu F; Hsu HK; Hsu PY; Wu J; Ma Y; Parvin J; Huang TH; Jin VX
BMC Syst Biol; 2010 Dec; 4():170. PubMed ID: 21167036
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a transcription factors-based prognostic signature for ovarian cancer.
Cheng Q; Li L; Yu M
J Ovarian Res; 2022 Feb; 15(1):29. PubMed ID: 35227285
[TBL] [Abstract][Full Text] [Related]
9. Screening the molecular targets of ovarian cancer based on bioinformatics analysis.
Du L; Qian X; Dai C; Wang L; Huang D; Wang S; Shen X
Tumori; 2015; 101(4):384-9. PubMed ID: 25953442
[TBL] [Abstract][Full Text] [Related]
10. Network analysis of microRNAs and their regulation in human ovarian cancer.
Schmeier S; Schaefer U; Essack M; Bajic VB
BMC Syst Biol; 2011 Nov; 5():183. PubMed ID: 22050994
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of MicroRNA-375 Promoter Methylation in Promoting Ovarian Cancer Cell Malignancy.
Shu J; Xiao L; Yan S; Fan B; Zou X; Yang J
Technol Cancer Res Treat; 2021; 20():1533033820980115. PubMed ID: 33928819
[TBL] [Abstract][Full Text] [Related]
12. Database for exploration of functional context of genes implicated in ovarian cancer.
Kaur M; Radovanovic A; Essack M; Schaefer U; Maqungo M; Kibler T; Schmeier S; Christoffels A; Narasimhan K; Choolani M; Bajic VB
Nucleic Acids Res; 2009 Jan; 37(Database issue):D820-3. PubMed ID: 18790805
[TBL] [Abstract][Full Text] [Related]
13. Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer.
Benhadjeba S; Edjekouane L; Sauvé K; Carmona E; Tremblay A
Mol Oncol; 2018 Oct; 12(10):1689-1705. PubMed ID: 30051594
[TBL] [Abstract][Full Text] [Related]
14. Identification of upstream regulators for prognostic expression signature genes in colorectal cancer.
Bae T; Rho K; Choi JW; Horimoto K; Kim W; Kim S
BMC Syst Biol; 2013 Sep; 7():86. PubMed ID: 24006872
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers.
Huang RL; Gu F; Kirma NB; Ruan J; Chen CL; Wang HC; Liao YP; Chang CC; Yu MH; Pilrose JM; Thompson IM; Huang HC; Huang TH; Lai HC; Nephew KP
Epigenetics; 2013 Jun; 8(6):624-34. PubMed ID: 23774800
[TBL] [Abstract][Full Text] [Related]
16. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J
Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955
[TBL] [Abstract][Full Text] [Related]
17. Identification of key genes associated with the effect of estrogen on ovarian cancer using microarray analysis.
Zhang ST; Zuo C; Li WN; Fu XQ; Xing S; Zhang XP
Arch Gynecol Obstet; 2016 Feb; 293(2):421-7. PubMed ID: 26264810
[TBL] [Abstract][Full Text] [Related]
18. Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival.
Batra J; Tan OL; O'Mara T; Zammit R; Nagle CM; Clements JA; Kedda MA; Spurdle AB
Int J Gynecol Cancer; 2010 May; 20(4):529-36. PubMed ID: 20686372
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-related transcription factor regulatory networks in human colorectal cancer.
Hao S; Huo S; Du Z; Yang Q; Ren M; Liu S; Liu T; Zhang G
Medicine (Baltimore); 2019 Apr; 98(15):e15158. PubMed ID: 30985693
[TBL] [Abstract][Full Text] [Related]
20. A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours.
Russell MR; Graham C; D'Amato A; Gentry-Maharaj A; Ryan A; Kalsi JK; Ainley C; Whetton AD; Menon U; Jacobs I; Graham RLJ
Br J Cancer; 2017 Aug; 117(5):666-674. PubMed ID: 28664912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
